Baidu
map

JAMA OHNS:烟酒或延长头颈部肿瘤患者留置胃管时间

2015-03-21 MedSci MedSci原创

JAMA Otolaryngology-Head & Neck Surgery最新在线发表的一项研究报告显示,吸烟和过量饮酒的将可能成为头颈部肿瘤患者接受放疗或化疗放置胃管时间延长的危险因素之一。该研究的背景介绍指出,对于晚期头颈部肿瘤患者而言,放化疗是一个行之有效的治疗方法。然而,放化疗相应带来的毒副性作用则将降低食欲进而引起体重下降和营养不良。因此,许多机构推荐在患者接受放化疗之前预防

p44_b
JAMA Otolaryngology-Head & Neck Surgery最新在线发表的一项研究报告显示,吸烟和过量饮酒的将可能成为头颈部肿瘤患者接受放疗或化疗放置胃管时间延长的危险因素之一。

该研究的背景介绍指出,对于晚期头颈部肿瘤患者而言,放化疗是一个行之有效的治疗方法。然而,放化疗相应带来的毒副性作用则将降低食欲进而引起体重下降和营养不良。因此,许多机构推荐在患者接受放化疗之前预防性置入胃管,以提供营养进入机体的渠道。然而,留置胃管时间的延长却可能带来一系列的不良影响。目前并无相关文献对影响留置胃管时间的风险因素进行研究报道。

爱尔兰维多利亚大学南方医院的Patrick Sheahan博士及其合作者共同研究了吸烟和饮酒对延长留置胃管时间的潜在危险性进行的研究探讨。

这项研究入组了104名患在一个教学医院接受治疗的头颈部鳞状细胞癌患者,其中接受放化疗的有84例,单独接受放疗的有20例。研究人员发现,该群患者的留置胃管的中位持续时间为9个月,其中留置胃管持续了12个月的占总体的35%。

据研究人员统计,延长留置胃管时间的风险因素为当前大量饮酒(每天饮酒、每周饮酒超过一定量、有酗酒历史、患与酒精有关的疾病以及尚未戒酒)(危险比[HR]为0.55,95%置信区间为0.32-0.97,P =0.04) 和当前吸烟 (危险比[HR]为0.47, 95%置信区间为0.27-0.81,P =0.01),其中当前吸烟是多变量分析中所提示的独立的危险因素 (危险比[HR]为0.53,95%置信区间为0.30-0.94,P =0.03)。而年龄因素中的65岁或以上、进展T分期、喉部和/或咽部原发肿瘤部位、治疗后颈部解剖结构均不是留置胃管时间延长的风险因素。

对于吸烟和饮酒影响留置胃管时间延长的因素,作者推测可能会有以下几个原因:烟草燃烧时产生的尼古丁可能抑制患者的食欲,因此患者未能尽力及早经口进食;吸烟和饮酒均可能导致病人治疗后恢复饮食的动力有所减弱。

Patrick Sheahan博士指出:“基于我们的研究结果,建议头颈部鳞状细胞癌(鳞状细胞癌) 患者在接受放疗或放化疗治疗期间避免吸烟和过量饮酒。然而,停止抽烟和喝酒是否可以缩短留置胃管的持续时间将需要进一步的前瞻性研究的数据来探讨。”

原始出处:
Ross O’Shea, Helen Byrne, Joel Tuckett, Gerard O’Leary, Patrick Sheahan.Impact of Current Smoking and Alcohol Consumption on Gastrostomy Duration in Patients With Head and Neck Cancer Undergoing Definitive Chemoradiotherapy. JAMA Otolaryngology–Head & Neck Surgery, 2015; DOI:10.1001/jamaoto.2015.0279

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1670090, encodeId=30bc16e009028, content=<a href='/topic/show?id=809ce0322c0' target=_blank style='color:#2F92EE;'>#留置#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70322, encryptionId=809ce0322c0, topicName=留置)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=532e26580241, createdName=xuyong532, createdTime=Sun Jul 12 14:23:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22148, encodeId=736f221484a, content=有意思的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91c51554277, createdName=jbliufj, createdTime=Tue Apr 28 07:53:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20042, encodeId=5a7c2004242, content=不错的选题, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Fri Apr 10 07:04:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424140, encodeId=7547142414096, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491760, encodeId=2f7e1491e604e, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44423, encryptionId=b4f14442346, topicName=头颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b2d8903151, createdName=wshxjq, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589683, encodeId=84a81589683eb, content=<a href='/topic/show?id=124d10065220' target=_blank style='color:#2F92EE;'>#颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100652, encryptionId=124d10065220, topicName=颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c46a17776631, createdName=木头人519, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-07-12 xuyong532
  2. [GetPortalCommentsPageByObjectIdResponse(id=1670090, encodeId=30bc16e009028, content=<a href='/topic/show?id=809ce0322c0' target=_blank style='color:#2F92EE;'>#留置#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70322, encryptionId=809ce0322c0, topicName=留置)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=532e26580241, createdName=xuyong532, createdTime=Sun Jul 12 14:23:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22148, encodeId=736f221484a, content=有意思的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91c51554277, createdName=jbliufj, createdTime=Tue Apr 28 07:53:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20042, encodeId=5a7c2004242, content=不错的选题, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Fri Apr 10 07:04:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424140, encodeId=7547142414096, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491760, encodeId=2f7e1491e604e, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44423, encryptionId=b4f14442346, topicName=头颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b2d8903151, createdName=wshxjq, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589683, encodeId=84a81589683eb, content=<a href='/topic/show?id=124d10065220' target=_blank style='color:#2F92EE;'>#颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100652, encryptionId=124d10065220, topicName=颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c46a17776631, createdName=木头人519, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-04-28 jbliufj

    有意思的研究

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1670090, encodeId=30bc16e009028, content=<a href='/topic/show?id=809ce0322c0' target=_blank style='color:#2F92EE;'>#留置#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70322, encryptionId=809ce0322c0, topicName=留置)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=532e26580241, createdName=xuyong532, createdTime=Sun Jul 12 14:23:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22148, encodeId=736f221484a, content=有意思的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91c51554277, createdName=jbliufj, createdTime=Tue Apr 28 07:53:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20042, encodeId=5a7c2004242, content=不错的选题, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Fri Apr 10 07:04:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424140, encodeId=7547142414096, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491760, encodeId=2f7e1491e604e, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44423, encryptionId=b4f14442346, topicName=头颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b2d8903151, createdName=wshxjq, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589683, encodeId=84a81589683eb, content=<a href='/topic/show?id=124d10065220' target=_blank style='color:#2F92EE;'>#颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100652, encryptionId=124d10065220, topicName=颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c46a17776631, createdName=木头人519, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-04-10 zhouanxiu

    不错的选题

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1670090, encodeId=30bc16e009028, content=<a href='/topic/show?id=809ce0322c0' target=_blank style='color:#2F92EE;'>#留置#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70322, encryptionId=809ce0322c0, topicName=留置)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=532e26580241, createdName=xuyong532, createdTime=Sun Jul 12 14:23:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22148, encodeId=736f221484a, content=有意思的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91c51554277, createdName=jbliufj, createdTime=Tue Apr 28 07:53:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20042, encodeId=5a7c2004242, content=不错的选题, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Fri Apr 10 07:04:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424140, encodeId=7547142414096, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491760, encodeId=2f7e1491e604e, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44423, encryptionId=b4f14442346, topicName=头颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b2d8903151, createdName=wshxjq, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589683, encodeId=84a81589683eb, content=<a href='/topic/show?id=124d10065220' target=_blank style='color:#2F92EE;'>#颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100652, encryptionId=124d10065220, topicName=颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c46a17776631, createdName=木头人519, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1670090, encodeId=30bc16e009028, content=<a href='/topic/show?id=809ce0322c0' target=_blank style='color:#2F92EE;'>#留置#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70322, encryptionId=809ce0322c0, topicName=留置)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=532e26580241, createdName=xuyong532, createdTime=Sun Jul 12 14:23:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22148, encodeId=736f221484a, content=有意思的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91c51554277, createdName=jbliufj, createdTime=Tue Apr 28 07:53:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20042, encodeId=5a7c2004242, content=不错的选题, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Fri Apr 10 07:04:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424140, encodeId=7547142414096, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491760, encodeId=2f7e1491e604e, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44423, encryptionId=b4f14442346, topicName=头颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b2d8903151, createdName=wshxjq, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589683, encodeId=84a81589683eb, content=<a href='/topic/show?id=124d10065220' target=_blank style='color:#2F92EE;'>#颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100652, encryptionId=124d10065220, topicName=颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c46a17776631, createdName=木头人519, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-03-23 wshxjq
  6. [GetPortalCommentsPageByObjectIdResponse(id=1670090, encodeId=30bc16e009028, content=<a href='/topic/show?id=809ce0322c0' target=_blank style='color:#2F92EE;'>#留置#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70322, encryptionId=809ce0322c0, topicName=留置)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=532e26580241, createdName=xuyong532, createdTime=Sun Jul 12 14:23:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22148, encodeId=736f221484a, content=有意思的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91c51554277, createdName=jbliufj, createdTime=Tue Apr 28 07:53:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20042, encodeId=5a7c2004242, content=不错的选题, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Fri Apr 10 07:04:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424140, encodeId=7547142414096, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491760, encodeId=2f7e1491e604e, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44423, encryptionId=b4f14442346, topicName=头颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b2d8903151, createdName=wshxjq, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589683, encodeId=84a81589683eb, content=<a href='/topic/show?id=124d10065220' target=_blank style='color:#2F92EE;'>#颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100652, encryptionId=124d10065220, topicName=颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c46a17776631, createdName=木头人519, createdTime=Mon Mar 23 02:23:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]

相关资讯

Ann Intern Med :警惕患者中央静脉管留置

根据一项发表在《内科学年鉴》的研究显示,约20%曾接受过不同级别培训的临床医师未意识到他们所负责住院患者的中央置管位置。 来自密歇根大学的维尼特博士及他的同事写到,"这是有史以来针对不同地区、不同技术水平以及不同领域的临床医师未意识到中央静脉导管定位的首次检查研究。” "参加教学培训至少能够令其意识到中央静脉导管的位置,"他们补充道,"因为对中央静脉导管的早期移动需要相应的定位知识,这些发现能

Baidu
map
Baidu
map
Baidu
map